Mitochondrial dysfunction due to aberrant mTOR-regulated mitophagy in autism

自闭症患者 mTOR 调节的线粒体自噬异常导致线粒体功能障碍

基本信息

  • 批准号:
    8509907
  • 负责人:
  • 金额:
    $ 18.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-03 至 2017-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This Mentored Research Scientist Development Award (K01) is designed to characterize the molecular mechanism underlying mitochondrial dysfunction in autism, with the eventual goal of identifying therapeutic interventions for mitochondrial defects. The applicant (Dr. Guomei Tang) is an Associate Research Scientist at Columbia University Medical Center (CUMC), where internationally renowned basic neuroscience research in psychiatry has been ongoing for many years. CUMC provides a rich environment that supports and encourages Dr. Tang's development and this K01 award will be instrumental for her successful transition to an independent research investigator. Dr. Tang has recruited an outstanding team of mentors, co-mentors, consultants and collaborators with extensive experience in mitochondrial biology and diseases, neuropathology, psychiatry neuropathology, neuroscience, molecular and cell biology, and mTOR-autophagy signaling. These experts will provide her with critical guidance and advice, and enhance her technical and scientific skills for the proposed research. The career development activities include tutorials, directed readings, course work, workshops for mitochondrial biology, skills in collaborating with clinicians and senior scientists, grant writing and presentations, and responsible conduct of research. Dr. Tang's long term research goal is to elucidate the molecular and cellular mechanisms underlying synaptic pathology in autism, and to provide insights into the pathogenesis and potential treatment for autism. To accomplish this, Dr. Tang will use a multidisciplinary approach combining biochemical, histological and imaging techniques to examine mitochondrial autophagy in postmortem autistic brain and mouse models. Her preliminary evidence indicates an association between mitochondrial defects and a dysregulation of mTOR-autophagy signaling in autistic brain. In mouse embryonic fibroblasts (MEFs) and neuronal cultures, mTOR hyperactivation inhibits autophagy, decreases mitochondrial membrane potential and causes an accumulation of damaged mitochondria. These results suggest that mitochondrial dysfunction in autism may result from aberrant mTOR- mediated mitophagy signaling. To address this hypothesis, Dr. Tang proposes 3 specific aims: 1) To determine whether mTOR hyperregulation inhibits neuronal mitophagy and causes mitochondrial dysfunction in ASD mouse models; 2) To examine whether enhancing mitophagy rescues mitochondrial dysfunction in ASD mouse models; and 3) To confirm mitophagy defects in ASD postmortem brain and lymphoblasts. These data will be important for understanding the mechanism by which mTOR kinase regulates mitophagy, elucidating the mitochondrial pathophysiology that underlies ASD pathogenesis, and ultimately to design interventions effective in treatment. The knowledge and experience gained from this proposal will lead directly to a study of the effects of mitophagy defects and mitochondria dysfunction on synaptic pathology in autism, which will be proposed in an R01 grant application in 3-4 years of the award.
该指导研究科学家发展奖(K 01)旨在表征自闭症线粒体功能障碍的分子机制,最终目标是确定线粒体缺陷的治疗干预措施。申请人(Guomei Tang博士)是哥伦比亚大学医学中心(Columbia University Medical Center)的副研究科学家,该中心多年来一直在进行国际知名的精神病学基础神经科学研究。CNOC提供了一个丰富的环境,支持和鼓励唐博士的发展,这个K 01奖将有助于她成功地过渡到一个独立的研究调查员。Tang博士招募了一支优秀的导师,共同导师,顾问和合作者团队,他们在线粒体生物学和疾病,神经病理学,精神病学神经病理学,神经科学,分子和细胞生物学以及mTOR-自噬信号传导方面拥有丰富的经验。这些专家将为她提供重要的指导和建议,并提高她的技术和科学技能,以进行拟议的研究。职业发展活动包括教程,定向阅读,课程工作,线粒体生物学研讨会,与临床医生和高级科学家合作的技能,赠款写作和演示,以及负责任的研究行为。唐博士的长期研究目标是阐明自闭症突触病理学的分子和细胞机制,并为自闭症的发病机制和潜在治疗提供见解。为了实现这一目标,Tang博士将使用多学科方法,结合生物化学,组织学和成像技术来研究死后自闭症大脑和小鼠模型中的线粒体自噬。她的初步证据表明线粒体缺陷与自闭症大脑中mTOR-自噬信号失调之间存在关联。在小鼠胚胎成纤维细胞(MEF)和神经元培养物中,mTOR超活化抑制自噬,降低线粒体膜电位并引起受损线粒体的积累。这些结果表明自闭症中的线粒体功能障碍可能是由异常的mTOR介导的线粒体自噬信号传导引起的。为了解决这一假设,Tang博士提出了3个具体目标:1)确定mTOR过度调节是否抑制ASD小鼠模型中的神经元线粒体自噬并导致线粒体功能障碍; 2)检查增强线粒体自噬是否挽救ASD小鼠模型中的线粒体功能障碍; 3)确认ASD死后脑和淋巴母细胞中的线粒体自噬缺陷。这些数据对于理解mTOR激酶调节线粒体自噬的机制、阐明ASD发病机制的线粒体病理生理学以及最终设计有效的治疗干预措施将是重要的。从该提案中获得的知识和经验将直接导致研究线粒体自噬缺陷和线粒体功能障碍对自闭症突触病理学的影响,该研究将在获奖后3-4年内在R 01赠款申请中提出。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Guomei Tang其他文献

Guomei Tang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Guomei Tang', 18)}}的其他基金

Cellular and Molecular basis for cognitive impairment associated with Glucocerebrosidase (GBA1) mutation
葡萄糖脑苷脂酶(GBA1)突变相关认知障碍的细胞和分子基础
  • 批准号:
    9789699
  • 财政年份:
    2018
  • 资助金额:
    $ 18.36万
  • 项目类别:
Cellular and Molecular basis for cognitive impairment associated with Glucocerebrosidase (GBA1) mutation
葡萄糖脑苷脂酶(GBA1)突变相关认知障碍的细胞和分子基础
  • 批准号:
    10462591
  • 财政年份:
    2018
  • 资助金额:
    $ 18.36万
  • 项目类别:
Cellular and Molecular basis for cognitive impairment associated with Glucocerebrosidase (GBA1) mutation
葡萄糖脑苷脂酶(GBA1)突变相关认知障碍的细胞和分子基础
  • 批准号:
    10227055
  • 财政年份:
    2018
  • 资助金额:
    $ 18.36万
  • 项目类别:
Cellular and Molecular basis for cognitive impairment associated with Glucocerebrosidase (GBA1) mutation
葡萄糖脑苷脂酶(GBA1)突变相关认知障碍的细胞和分子基础
  • 批准号:
    9975950
  • 财政年份:
    2018
  • 资助金额:
    $ 18.36万
  • 项目类别:
Mitochondrial dysfunction due to aberrant mTOR-regulated mitophagy in autism
自闭症患者 mTOR 调节的线粒体自噬异常导致线粒体功能障碍
  • 批准号:
    8657109
  • 财政年份:
    2013
  • 资助金额:
    $ 18.36万
  • 项目类别:
Mitochondrial dysfunction due to aberrant mTOR-regulated mitophagy in autism
自闭症患者 mTOR 调节的线粒体自噬异常导致线粒体功能障碍
  • 批准号:
    9038442
  • 财政年份:
    2013
  • 资助金额:
    $ 18.36万
  • 项目类别:
Mitochondrial dysfunction due to aberrant mTOR-regulated mitophagy in autism
自闭症患者 mTOR 调节的线粒体自噬异常导致线粒体功能障碍
  • 批准号:
    8838258
  • 财政年份:
    2013
  • 资助金额:
    $ 18.36万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.36万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了